Fast Five Quiz: Do You Know Best Practices for Osteoporosis?

Herbert S. Diamond, MD


November 12, 2020

According to the NOF guidelines, pharmacologic treatment for osteoporosis should be initiated in postmenopausal women and men ≥ 50 years of age with low bone mass (T-score between -1.0 and -2.5, osteopenia) at the femoral neck, total hip, or lumbar spine by DEXA; and in patients with a 10-year hip fracture probability rate ≥ 3%, based on the US-adapted WHO absolute fracture risk model.

Other indications for pharmacologic therapy include hip or vertebral fractures or T-scores ≤ -2.5 at the femoral neck, total hip, or lumbar spine by DEXA.

Learn more about the treatment of osteoporosis.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.